Patents by Inventor Zhizhen Zheng

Zhizhen Zheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hepatitis C virus inhibitors
    Patent number: 8003604
    Abstract: Macrocyclic peptides having the general formula: are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: November 14, 2007
    Date of Patent: August 23, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Nicholas A. Meanwell, Paul Michael Scola
  • Hepatitis C virus inhibitors
    Patent number: 7888464
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: November 14, 2007
    Date of Patent: February 15, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Qian Zhao, Paul Michael Scola
  • Hepatitis C virus inhibitors
    Patent number: 7763584
    Abstract: Macrocyclic peptides having the general formula: are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: November 14, 2007
    Date of Patent: July 27, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Nicholas A. Meanwell, Paul Michael Scola
  • HEPATITIS C VIRUS INHIBITORS
    Publication number: 20090274648
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: November 14, 2007
    Publication date: November 5, 2009
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Qian Zhao, Paul Michael Scola
  • HEPATITIS C VIRUS INHIBITORS
    Publication number: 20080159982
    Abstract: Macrocyclic peptides having the general formula: are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: November 14, 2007
    Publication date: July 3, 2008
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Nicholas A. Meanwell, Paul Michael Scola
  • HEPATITIS C VIRUS INHIBITORS
    Publication number: 20080145334
    Abstract: Macrocyclic peptides having the general formula: are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: November 14, 2007
    Publication date: June 19, 2008
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Nicholas A. Meanwell, Paul Michael Scola
  • Inhibitors of Hepatitis C Virus
    Publication number: 20080107624
    Abstract: Macrocyclic peptides are disclosed having the general formula: wherein R3, R?3, R4, R6, R?, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: October 25, 2007
    Publication date: May 8, 2008
    Inventors: Stanley D'Andrea, Zhizhen Zheng, Paul Scola
  • Hepatitis C virus inhibitors
    Publication number: 20070099825
    Abstract: Macrocyclic peptides are disclosed having the general formula: wherein R?, R3, R3?, R4, R6, X, Q, and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: November 1, 2006
    Publication date: May 3, 2007
    Inventors: Stanley D'Andrea, Zhizhen Zheng, Jeffrey Campbell, Fiona McPhee, Andrew Good, Paul Scola
  • Hepatitis C virus inhibitors
    Publication number: 20070093414
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: October 11, 2006
    Publication date: April 26, 2007
    Inventors: David Carini, Barry Johnson, Zhizhen Zheng, Stanley D'Andrea, Paul Scola
  • Macrocyclic isoquinoline peptide inhibitors of Hepatitis C virus
    Publication number: 20050090432
    Abstract: Macrocyclic isoquinoline peptides are disclosed having the general formula: A compound of formula I: wherein R1 to R9, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: April 16, 2004
    Publication date: April 28, 2005
    Inventors: Fiona McPhee, Jeffrey Campbell, Wenying Li, Stanley D'Andrea, Zhizhen Zheng, Andrew Good, David Carini, Barry Johnson, Paul Scola
  • Novel isoxazolinone antibacterial agents
    Publication number: 20020094984
    Abstract: This invention describes isoxazolinone derivatives which possess antibacterial activity and are useful in the treatment of bacterial diseases.
    Type: Application
    Filed: February 13, 2001
    Publication date: July 18, 2002
    Inventors: Lawrence B. Snyder, Zhizhen Zheng
  • Isoxazolinone antibacterial agents
    Patent number: 6420349
    Abstract: This invention describes isoxazolinone compounds which possess antibacterial activity and are useful in the treatment of bacterial diseases.
    Type: Grant
    Filed: February 13, 2001
    Date of Patent: July 16, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Lawrence B. Snyder, Zhizhen Zheng